Anti-IL2 monoclonal antibody, clone MQ1-17H12 [FITC]
Product Details
- Cat. No.
- CABT-48483RH
- Type
- Primary Antibody
- Clonality
- Monoclonal
- Host
- Rat
The supplier does not provide quotations for this antibody through SelectScience. You can search for similar antibodies in our Antibody Directory.
Description
Rat Anti-Human IL2 monoclonal antibody for FC. Rat anti Human Interleukin-2 antibody, clone MQ1-17H12 recognizes human interleukin-2 (IL-2), also known as T-cell growth factor or Aldesleukin. IL-2 is a 153 amino acid secreted cytokine produced by T-cells following antigenic or mitogenic stimulation. It plays a crucial role in T-cell proliferation and immune regulation. Rat anti Human Interleukin-2 antibody, clone MQ1-17H12 has been sucessfully used for the detection and measurement of native and recombinant human IL-2 using flow cytometry and ELISA where it ascts as the capture reagent in a very sensitive assay for IL-2 determination in human samples. IL-2 is used extensively for the treatment of patients with metastatic melanoma and renal cancer with repriducible benificial effects. Monitoring of IL-2 levels in such patients is required for optimization of treatment regimens. Rat anti Human Interleukin-2 antibody, clone MQ1-17H12 is also useful for evaluating levels of IL-2 in patients with autoimmune conditions including lupus erythematosus and rheumatoid arthritis where there may be an impaired ability to produce IL-2. Flow Cytometry Use 10ul of the suggested working dilution to label 1x106 cells in 100ul. Applications:FC
Biological Information
- Clonality: Monoclonal
- Host: Rat
- Reactivity: Cynomolgus Monkey, Human
- Conjugate: FITC
- Isotype: IgG2a
- Gene: 3558
Handling
- Quantity: 100 μg
- Storage: in frost free freezers is not recommended. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
- Specificity: 4
Applications
- Flow Cytometry (FC)
Flow ctyometry
The antibody is effective for the analysis and examines the results of the study
Review Date: 27 Jun 2023 | Creative Diagnostics